|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prat J: New insights into ovarian cancer
pathology. Ann Oncol. 23(Suppl 10): x111–x117. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lheureux S, Gourley C, Vergote I and Oza
AM: Epithelial ovarian cancer. Lancet. 393:1240–1253. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Castro-Oropeza R, Melendez-Zajgla J,
Maldonado V and Vazquez-Santillan K: The emerging role of lncRNAs
in the regulation of cancer stem cells. Cell Oncol (Dordr).
41:585–603. 2018. View Article : Google Scholar
|
|
5
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang X, Hamblin MH and Yin KJ: The long
noncoding RNA malat1: Its physiological and pathophysiological
functions. RNA Biol. 14:1705–1714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mitra R, Chen X, Greenawalt EJ, Maulik U,
Jiang W, Zhao Z and Eischen CM: Decoding critical long non-coding
RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat
Commun. 8:16042017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu DD, Chen X, Sun KX, Wang LL, Chen S and
Zhao Y: Role of the lncRNA ABHD11-AS1 in the tumorigenesis and
progression of epithelial ovarian cancer through targeted
regulation of RhoC. Mol Cancer. 16:1382017. View Article : Google Scholar :
|
|
10
|
Yang L, Xue Y, Liu J, Zhuang J, Shen L,
Shen B, Yan J and Guo H: Long noncoding RNA ASAP1-IT1 promotes
cancer stemness and predicts a poor prognosis in patients with
bladder cancer. Neoplasma. 64:847–855. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fu Y, Biglia N, Wang Z, Shen Y, Risch HA,
Lu L, Canuto EM, Jia W, Katsaros D and Yu H: Long non-coding RNAs,
ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer.
Gynecol Oncol. 143:642–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu FX, Zhao B, Panupinthu N, Jewell JL,
Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, et al:
Regulation of the Hippo-YAP pathway by G-protein-coupled receptor
signaling. Cell. 150:780–791. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Overholtzer M, Zhang J, Smolen GA, Muir B,
Li W, Sgroi DC, Deng CX, Brugge JS and Haber DA: Transforming
properties of YAP, a candidate oncogene on the chromosome 11q22
amplicon. Proc Natl Acad Sci USA. 103:12405–12410. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pan Y, Tong JHM, Lung RWM, Kang W, Kwan
JSH, Chak WP, Tin KY, Chung LY, Wu F, Ng SSM, et al: RASAL2
promotes tumor progression through LATS2/YAP1 axis of hippo
signaling pathway in colorectal cancer. Mol Cancer. 17:1022018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong L, Lin F, Wu W, Liu Y and Huang W:
Verteporfin inhibits YAP-induced bladder cancer cell growth and
invasion via Hippo signaling pathway. Int J Med Sci. 15:645–652.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu S, Cai X, Wu C, Wu L, Wang Y, Liu Y, Yu
Z, Qin S, Ma F, Thiery JP and Chen L: Adhesion glycoprotein CD44
functions as an upstream regulator of a network connecting ERK, AKT
and Hippo-YAP pathways in cancer progression. Oncotarget.
6:2951–2965. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan H, Li H, Silva MA, Guan Y, Yang L, Zhu
L, Zhang Z, Li G and Ren C: LncRNA FLVCR1-AS1 mediates miR-513/YAP1
signaling to promote cell progression, migration, invasion and EMT
process in ovarian cancer. J Exp Clin Cancer Res. 38:3562019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yan H, Li H, Li P, Li X, Lin J, Zhu L,
Silva MA, Wang X, Wang P and Zhang Z: Long noncoding RNA MLK7-AS1
promotes ovarian cancer cells progression by modulating
miR-375/YAP1 axis. J Exp Clin Cancer Res. 37:2372018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo C, Wang X and Liang L: LATS2-mediated
YAP1 phosphorylation is involved in HCC tumorigenesis. Int J Clin
Exp Pathol. 8:1690–1697. 2015.PubMed/NCBI
|
|
20
|
Guo Y, Cui J, Ji Z, Cheng C, Zhang K,
Zhang C, Chu M, Zhao Q, Yu Z, Zhang Y, et al: miR-302/367/LATS2/YAP
pathway is essential for prostate tumor-propagating cells and
promotes the development of castration resistance. Oncogene.
36:6336–6347. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia Y and Gao Y: MicroRNA-181b promotes
ovarian cancer cell growth and invasion by targeting LATS2. Biochem
Biophys Res Commun. 447:446–451. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Chen Y and Wang X: miRDB: An online
database for prediction of functional microRNA targets. Nucleic
Acids Res. 48(D1): D127–D131. 2020. View Article : Google Scholar :
|
|
24
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar :
|
|
25
|
Cordenonsi M, Zanconato F, Azzolin L,
Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR,
Poletti A, et al: The Hippo transducer TAZ confers cancer stem
cell-related traits on breast cancer cells. Cell. 147:759–772.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Melhem A, Yamada SD, Fleming GF, Delgado
B, Brickley DR, Wu W, Kocherginsky M and Conzen SD: Administration
of glucocorticoids to ovarian cancer patients is associated with
expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in
ovarian tissues. Clin Cancer Res. 15:3196–3204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li R, Wang Y, Xu Y, He X and Li Y:
Silencing the long noncoding RNA, TINCR, a molecular sponge of
miR335, inhibits the malignant phenotype of epithelial ovarian
cancer via FGF2 suppression. Int J Oncol. 55:1110–1124.
2019.PubMed/NCBI
|
|
28
|
Llaurado M, Abal M, Castellvi J, Cabrera
S, Gil-Moreno A, Pérez-Benavente A, Colás E, Doll A, Dolcet X,
Matias-Guiu X, et al: ETV5 transcription factor is overexpressed in
ovarian cancer and regulates cell adhesion in ovarian cancer cells.
Int J Cancer. 130:1532–1543. 2012. View Article : Google Scholar
|
|
29
|
Todeschini P, Salviato E, Paracchini L,
Ferracin M, Petrillo M, Zanotti L, Tognon G, Gambino A, Calura E,
Caratti G, et al: Circulating miRNA landscape identifies miR-1246
as promising diagnostic biomarker in high-grade serous ovarian
carcinoma: A validation across two independent cohorts. Cancer
Lett. 388:320–327. 2017. View Article : Google Scholar
|
|
30
|
Li J, Yang C, Li Y, Chen A, Li L and You
Z: LncRNA GAS5 suppresses ovarian cancer by inducing inflammasome
formation. Biosci Rep. 38:BSR201711502018. View Article : Google Scholar :
|
|
31
|
An J, Lv W and Zhang Y: LncRNA NEAT1
contributes to paclitaxel resistance of ovarian cancer cells by
regulating ZEB1 expression via miR-194. Onco Targets Ther.
10:5377–5390. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Muller T, Stein U, Poletti A, Garzia L,
Rothley M, Plaumann D, Thiele W, Bauer M, Galasso A, Schlag P, et
al: ASAP1 promotes tumor cell motility and invasiveness, stimulates
metastasis formation in vivo, and correlates with poor survival in
colorectal cancer patients. Oncogene. 29:2393–2403. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang L, Shi SB, Zhu Y, Qian TT and Wang
HL: Long non-coding RNA ASAP1-IT1 promotes cell proliferation,
invasion and metastasis through the PTEN/AKT signaling axis in
non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 22:142–149.
2018.PubMed/NCBI
|
|
35
|
Guo L, Zhou Y, Chen Y, Sun H, Wang Y and
Qu Y: LncRNA ASAP1-IT1 positively modulates the development of
cholangiocarcinoma via hedgehog signaling pathway. Biomed
Pharmacother. 103:167–173. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Y, Justilien V, Brennan KI, Jamieson
L, Murray NR and Fields AP: PKCiota regulates nuclear YAP1
localization and ovarian cancer tumorigenesis. Oncogene.
36:534–545. 2017. View Article : Google Scholar
|
|
37
|
He C, Lv X, Huang C, Hua G, Ma B, Chen X,
Angeletti PC, Dong J, Zhou J, Wang Z, et al: YAP1-LATS2 feedback
loop dictates senescent or malignant cell fate to maintain tissue
homeostasis. EMBO Rep. 20:e449482019. View Article : Google Scholar : PubMed/NCBI
|
